Novartis, GSK, Lilly sign multibillion-dollar deals to trade business units
GENEVA - Drugmaker Novartis says it has signed several multibillion-dollar deals with GlaxoSmithKline and Lilly that will affect some 15,000 of its employees.
The Basel, Switzerland-based company said Tuesday it will buy GSK's oncology products business for $14.5 billion, plus up to $1.5 billion more if certain milestones are met.
It will also divest its vaccines business to GSK, excluding its flu business, for $7.1 billion, plus royalties. The two companies are also creating a new consumer health care business through a joint venture.
Separately, Novartis said it will sell off its animal health division to Lilly for about $5.4 billion and plans to sell its flu business.
Novartis CEO Joseph Jimenez told reporters the transactions will raise profits and "affect 15,000 Novartis employees," but didn't specify in which way.
Read more Business News
- Legebokoff gets life sentenceBC - 12:26 pm
- Jaws of Life needed for crashKelowna - 1:03 pm
- Teachers reach dealBC - 6:28 am
- Schools ready to welcome kidsCentral Okanagan - 11:55 am
|QHR Technologies Inc||1.30||+0.01|
|Anavex Life Sciences||0.25||0.00|
|Copper Mountain Mining||2.69||-0.01|
|Sunrise Resources Ltd||0.02||-0.005|
|Mission Ready Services||0.30||+0.035|
Part 1 of 2 Photo: Thinkstock.com1. Move in with your parents or in-laws Explain that you're thinking strategically in moving back home. The quickest way to get into the housing market is to ma...
Article written by Linda Bustos Though I’d never recommend “lowest prices” as a unique selling proposition, I notice many retailers use a Price Match Guarantee or even a 110% Guara...
This week my wife wrote a blog for our charities website, I thought you may enjoy reading it here: I was planning to write about the incredible philanthropic Miss Angelina when, funnily enough, she ...